[go: up one dir, main page]

SG11201508912YA - 2-PHENYL OR 2-HETARYL IMIDAZOL[1,2-a]PYRIDINE DERIVATIVES - Google Patents

2-PHENYL OR 2-HETARYL IMIDAZOL[1,2-a]PYRIDINE DERIVATIVES

Info

Publication number
SG11201508912YA
SG11201508912YA SG11201508912YA SG11201508912YA SG11201508912YA SG 11201508912Y A SG11201508912Y A SG 11201508912YA SG 11201508912Y A SG11201508912Y A SG 11201508912YA SG 11201508912Y A SG11201508912Y A SG 11201508912YA SG 11201508912Y A SG11201508912Y A SG 11201508912YA
Authority
SG
Singapore
Prior art keywords
hetaryl
imidazol
phenyl
pyridine derivatives
pyridine
Prior art date
Application number
SG11201508912YA
Inventor
Edilio Borroni
Luca Gobbi
Michael Honer
Henner Knust
Matthias Koerner
Dieter Muri
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG11201508912YA publication Critical patent/SG11201508912YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201508912YA 2013-04-29 2014-04-25 2-PHENYL OR 2-HETARYL IMIDAZOL[1,2-a]PYRIDINE DERIVATIVES SG11201508912YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13165676 2013-04-29
PCT/EP2014/058415 WO2014177458A1 (en) 2013-04-29 2014-04-25 2-PHENYL OR 2-HETARYL IMIDAZOL[1,2-a]PYRIDINE DERIVATIVES

Publications (1)

Publication Number Publication Date
SG11201508912YA true SG11201508912YA (en) 2015-11-27

Family

ID=48190297

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201508912YA SG11201508912YA (en) 2013-04-29 2014-04-25 2-PHENYL OR 2-HETARYL IMIDAZOL[1,2-a]PYRIDINE DERIVATIVES

Country Status (18)

Country Link
US (3) US10138234B2 (en)
EP (1) EP2991983B1 (en)
JP (1) JP6212628B2 (en)
KR (2) KR20160003173A (en)
CN (1) CN105164125B (en)
AR (1) AR096119A1 (en)
AU (1) AU2014261628A1 (en)
BR (1) BR112015027015A2 (en)
CA (1) CA2910368A1 (en)
DK (1) DK2991983T3 (en)
ES (1) ES2624453T3 (en)
MX (1) MX2015014353A (en)
PL (1) PL2991983T3 (en)
RU (1) RU2015147450A (en)
SG (1) SG11201508912YA (en)
SI (1) SI2991983T1 (en)
WO (1) WO2014177458A1 (en)
ZA (1) ZA201507389B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201508912YA (en) * 2013-04-29 2015-11-27 Hoffmann La Roche 2-PHENYL OR 2-HETARYL IMIDAZOL[1,2-a]PYRIDINE DERIVATIVES
BR112015025140A2 (en) * 2013-05-23 2017-07-18 Hoffmann La Roche 2-phenylimidazo [1,2-a] pyrimidines as imaging agents
CA2920068A1 (en) 2013-09-26 2015-04-02 F. Hoffmann-La Roche Ag Imidazo[1,2-a]pyridin-7-amines as imaging tools
DK3355699T3 (en) * 2015-09-29 2021-06-07 Onco Therapy Science Inc BICYCLIC COMPOUND AND ITS USE FOR INHIBITING SUV39H2
US10865207B2 (en) 2016-07-22 2020-12-15 Ac Immune S.A. Compounds for imaging Tau protein aggregates
MX386900B (en) 2016-07-22 2025-03-19 Ac Immune S A Star COMPOUNDS FOR IMAGING TAU PROTEIN AGGREGATES.
WO2018165112A1 (en) * 2017-03-09 2018-09-13 Oncotherapy Science, Inc. Bicyclic compound and use thereof for inhibiting histone methyltransferase
EP3743426A1 (en) 2018-01-24 2020-12-02 AC Immune SA Azacarboline compounds for the detection of tau aggregates
US11306089B2 (en) 2018-01-24 2022-04-19 Life Molecular Imaging Limited Gamma-carboline compounds for the detection of Tau aggregates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654436A (en) * 1995-06-07 1997-08-05 American Home Products Corporation 2-substituted benzimidazole derivatives
CA2444214A1 (en) 2001-04-23 2002-10-31 The Trustees Of The University Of Pennsylvania Amyloid plaque aggregation inhibitors and diagnostic imaging agents
EP1432453B1 (en) 2001-08-27 2013-08-14 The Trustees of The University of Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques
EP1956013B1 (en) * 2005-11-30 2016-04-13 Fujifilm RI Pharma Co., Ltd. Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
AU2007207053B2 (en) * 2006-01-17 2012-05-24 F. Hoffmann-La Roche Ag Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of Alzheimer's disease via GABA receptors
EP2023919A4 (en) * 2006-05-08 2010-12-22 Molecular Neuroimaging Llc Compounds and amyloid probes thereof for therapeutic and imaging uses
KR20090025282A (en) * 2006-06-21 2009-03-10 니혼 메디피직스 가부시키가이샤 New Amyloid Affinity Compounds
AU2007320581A1 (en) * 2006-11-17 2008-05-22 Nihon Medi-Physics Co., Ltd. Novel compounds with affinity for amyloid
RU2009124537A (en) 2007-01-22 2011-02-27 Астразенека Аб (Se) NEW HETEROARYL SUBSTITUTED IMIDAZO (1,2-a) PYRIDINES DERIVATIVES
US20150377123A1 (en) 2007-08-01 2015-12-31 United Technologies Corporation Turbine section of high bypass turbofan
EP2216052A4 (en) * 2007-10-30 2012-11-21 Nihon Mediphysics Co Ltd USE OF A NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID SUBSTANCES AND PROCESS FOR PRODUCING THE SAME
PT2338059E (en) 2008-09-23 2015-08-03 Wista Lab Ltd Ligands for aggregated tau molecules
ES2530884T3 (en) * 2009-09-24 2015-03-06 Hoffmann La Roche Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10A inhibitors
US8703768B2 (en) * 2010-06-09 2014-04-22 Hoffmann-La Roche Inc. Nitrogen containing heteroaryl compounds
SG11201508912YA (en) 2013-04-29 2015-11-27 Hoffmann La Roche 2-PHENYL OR 2-HETARYL IMIDAZOL[1,2-a]PYRIDINE DERIVATIVES
CA2920068A1 (en) * 2013-09-26 2015-04-02 F. Hoffmann-La Roche Ag Imidazo[1,2-a]pyridin-7-amines as imaging tools

Also Published As

Publication number Publication date
MX2015014353A (en) 2016-04-07
KR20160003173A (en) 2016-01-08
AR096119A1 (en) 2015-12-09
CA2910368A1 (en) 2014-11-06
SI2991983T1 (en) 2017-06-30
ZA201507389B (en) 2017-01-25
CN105164125A (en) 2015-12-16
EP2991983A1 (en) 2016-03-09
DK2991983T3 (en) 2017-05-08
WO2014177458A1 (en) 2014-11-06
PL2991983T3 (en) 2017-07-31
EP2991983B1 (en) 2017-03-01
AU2014261628A1 (en) 2015-10-22
US11358962B2 (en) 2022-06-14
US20160244441A1 (en) 2016-08-25
JP2016520046A (en) 2016-07-11
US10138234B2 (en) 2018-11-27
JP6212628B2 (en) 2017-10-11
ES2624453T3 (en) 2017-07-14
RU2015147450A (en) 2017-06-05
US20190048002A1 (en) 2019-02-14
KR20170094001A (en) 2017-08-16
CN105164125B (en) 2017-10-13
US20190048003A1 (en) 2019-02-14
HK1213555A1 (en) 2016-07-08
BR112015027015A2 (en) 2017-07-25
US10975073B2 (en) 2021-04-13

Similar Documents

Publication Publication Date Title
IL263404A (en) Ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
IL240112A0 (en) Halogen-substituted pyrazol derivatives as pest-control agents
ZA201507874B (en) 2-aminopyrido[4,3-d]pyrimidin-5-one derivatives and their use as wee-1 inhibitors
ZA201506570B (en) 2-phenylimidazo[1,2-a]pyrimidines as imaging agents
ZA201507389B (en) 2-phenyl or 2-hetaryl imidazol[1,2-a]pyridine derivatives
ZA201506747B (en) Imidazo pyridine compounds
IL240327B (en) Novel pyrazol derivatives
IL240496A0 (en) Novel pyridine derivatives
ZA201507657B (en) Pyridin-4-yl derivatives
EP2970278A4 (en) Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
IL244039A0 (en) Ethynyl derivatives
SG11201601135QA (en) 3-substituted cyclopentylamine derivatives
GB201300892D0 (en) Novel isothiazolo[4,3-b]pyridines
GB201314960D0 (en) Heterocyclic derivatives
GB201300306D0 (en) Heterocyclic derivatives